Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Oct 31, 2025 | (FY)Jul 31, 2025 | (Q4)Jul 31, 2025 | (Q3)Apr 30, 2025 | (Q2)Jan 31, 2025 | (Q1)Oct 31, 2024 | (FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -46.31%40.13K | -26.12%378.07K | -23.66%86.6K | -46.82%91K | -13.24%125.72K | -9.17%74.75K | 4.64%511.76K | 19.60%113.44K | 73.57%171.13K | 104.93%144.9K |
| Selling and administrative expenses | -46.31%40.13K | -26.62%378.07K | -25.94%86.6K | -46.82%91K | -13.24%125.72K | -9.17%74.75K | 5.36%515.25K | 23.28%116.93K | 73.62%171.13K | 104.93%144.9K |
| -General and administrative expense | -46.31%40.13K | -26.62%378.07K | -25.94%86.6K | -46.82%91K | -13.24%125.72K | -9.17%74.75K | 5.36%515.25K | 23.28%116.93K | 73.62%171.13K | 104.93%144.9K |
| Other operating expenses | ---- | ---- | ---- | ---- | ---- | ---- | -12,567.86%-3.49K | ---4.72K | 4,282.14%1.23K | ---- |
| Operating profit | 46.31%-40.13K | 26.12%-378.07K | 23.66%-86.6K | 46.82%-91K | 13.24%-125.72K | 9.17%-74.75K | -4.64%-511.76K | -19.60%-113.44K | -73.57%-171.13K | -104.93%-144.9K |
| Net non-operating interest income (expenses) | 104.57%2.19K | -116.65%-164.23K | -103.03%-202 | -207.82%-65.21K | -114.31%-50.87K | -27.73%-47.95K | 41.43%-75.81K | 104.73%6.66K | -218.47%-21.18K | -282.52%-23.74K |
| Non-operating interest income | -0.66%2.55K | -70.19%13.82K | --0 | -70.44%8.74K | -91.59%2.52K | -81.04%2.57K | -46.56%46.38K | 64.72%-26.69K | -55.91%29.56K | -52.98%29.97K |
| Non-operating interest expense | -99.29%359 | 14.13%178.06K | -57.65%202 | 45.74%73.95K | -0.59%53.39K | -1.11%50.52K | -20.88%156.01K | -98.97%477 | 3.24%50.74K | 5.85%53.71K |
| Total other finance cost | ---- | ---- | ---- | ---- | ---- | ---- | -277.78%-33.82K | ---- | ---- | ---- |
| Other net income (expenses) | 477.35%131.57K | -52,097.47%-740.44K | -705.58K | -34.87K | 94.54%1.42K | |||||
| Gain on sale of security | ---- | ---- | ---- | ---- | ---- | ---- | 94.54%1.42K | ---- | ---- | ---- |
| Special income (charges) | --0 | ---740.44K | ---705.58K | --0 | --0 | ---34.87K | --0 | --0 | --0 | --0 |
| -Less:Impairment of capital assets | ---- | --705.58K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Less:Write off | --0 | --34.87K | --0 | --0 | --0 | --34.87K | --0 | --0 | --0 | --0 |
| Other non-operating income (expenses) | --131.57K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | 159.42%93.63K | -118.85%-1.28M | -652.11%-792.38K | 18.76%-156.21K | -4.73%-176.59K | -31.48%-157.56K | 5.12%-586.14K | 55.16%-105.36K | -138.24%-192.29K | -192.21%-168.61K |
| Income tax | 0 | |||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 159.42%93.63K | -118.85%-1.28M | -652.11%-792.38K | 18.76%-156.21K | -4.73%-176.59K | -31.48%-157.56K | 3.17%-586.14K | 52.65%-105.36K | -138.24%-192.29K | -192.21%-168.61K |
| Net income continuous operations | 159.42%93.63K | -118.85%-1.28M | -652.11%-792.38K | 18.76%-156.21K | -4.73%-176.59K | -31.48%-157.56K | 3.17%-586.14K | 52.65%-105.36K | -138.24%-192.29K | -192.21%-168.61K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 159.42%93.63K | -118.85%-1.28M | -652.11%-792.38K | 18.76%-156.21K | -4.73%-176.59K | -31.48%-157.56K | 3.17%-586.14K | 52.65%-105.36K | -138.24%-192.29K | -192.21%-168.61K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 159.42%93.63K | -118.85%-1.28M | -652.11%-792.38K | 18.76%-156.21K | -4.73%-176.59K | -31.48%-157.56K | 3.17%-586.14K | 52.65%-105.36K | -138.24%-192.29K | -192.21%-168.61K |
| Diluted earnings per share | 140.00%0.002 | -115.79%-0.041 | -640.96%-0.025 | -400.00%-0.005 | -500.00%-0.006 | 0.00%-0.005 | 24.00%-0.019 | 66.26%-0.0034 | 80.00%-0.001 | 80.00%-0.001 |
| Basic earnings per share | 140.00%0.002 | -115.79%-0.041 | -640.96%-0.025 | -400.00%-0.005 | -500.00%-0.006 | 0.00%-0.005 | 24.00%-0.019 | 66.26%-0.0034 | 80.00%-0.001 | 80.00%-0.001 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.